Gaohong Sheng

1.0k total citations
22 papers, 661 citations indexed

About

Gaohong Sheng is a scholar working on Molecular Biology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gaohong Sheng has authored 22 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Rheumatology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gaohong Sheng's work include Osteoarthritis Treatment and Mechanisms (7 papers), Bone Tissue Engineering Materials (3 papers) and Natural product bioactivities and synthesis (2 papers). Gaohong Sheng is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (7 papers), Bone Tissue Engineering Materials (3 papers) and Natural product bioactivities and synthesis (2 papers). Gaohong Sheng collaborates with scholars based in China, United Kingdom and United States. Gaohong Sheng's co-authors include Huilan Zhang, Yuan Gao, Yang Yong, Hua Wu, Huihui Yue, Jiaojiao Chu, Yanqiu Wei, Jianping Zhao, Hua Wu and Peng Chen and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and CHEST Journal.

In The Last Decade

Gaohong Sheng

22 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaohong Sheng China 12 215 165 135 108 81 22 661
Maoming Xiong China 16 147 0.7× 331 2.0× 157 1.2× 246 2.3× 213 2.6× 47 874
Jiaqi Zhu United States 19 155 0.7× 365 2.2× 136 1.0× 70 0.6× 163 2.0× 51 1000
Yakun Wang China 11 114 0.5× 78 0.5× 98 0.7× 147 1.4× 44 0.5× 27 487
Junhong Jiang China 14 179 0.8× 160 1.0× 45 0.3× 77 0.7× 60 0.7× 53 551
Dongqing Lv China 13 225 1.0× 168 1.0× 56 0.4× 240 2.2× 88 1.1× 92 509
Jian Ding China 13 178 0.8× 322 2.0× 70 0.5× 187 1.7× 145 1.8× 32 819
Marko Jakopović Croatia 16 402 1.9× 234 1.4× 84 0.6× 262 2.4× 133 1.6× 93 937
Xiangyu Chen China 10 89 0.4× 70 0.4× 166 1.2× 75 0.7× 40 0.5× 34 443
Xiaogang Shu China 14 91 0.4× 422 2.6× 161 1.2× 246 2.3× 226 2.8× 23 840

Countries citing papers authored by Gaohong Sheng

Since Specialization
Citations

This map shows the geographic impact of Gaohong Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaohong Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaohong Sheng more than expected).

Fields of papers citing papers by Gaohong Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaohong Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaohong Sheng. The network helps show where Gaohong Sheng may publish in the future.

Co-authorship network of co-authors of Gaohong Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Gaohong Sheng. A scholar is included among the top collaborators of Gaohong Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaohong Sheng. Gaohong Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Tao, Ran Gao, Wenbin Liu, et al.. (2025). Poly-ε-caprolactone/chitosan/whitlockite electrospun bionic membrane conjugated with an E7 peptide for bone regeneration. Stem Cell Research & Therapy. 16(1). 212–212. 2 indexed citations
2.
Xu, Tao, et al.. (2024). Anti-Inflammatory and Antioxidant Effects of Irigenen Alleviate Osteoarthritis Progression through Nrf2/HO-1 Pathway. Pharmaceuticals. 17(10). 1268–1268. 2 indexed citations
3.
Jiang, Pan, et al.. (2024). The basic biology of NK cells and its application in tumor immunotherapy. Frontiers in Immunology. 15. 1420205–1420205. 15 indexed citations
4.
Xu, Tao, et al.. (2024). 2D MXene Nanosheets with ROS Scavenging Ability Effectively Delay Osteoarthritis Progression. Nanomaterials. 14(19). 1572–1572. 6 indexed citations
5.
Gao, Chenghao, Yi Zou, Liming Zhao, et al.. (2024). Single cell transcriptome profiling of infrapatellar fat pad highlights the role of interstitial inflammatory fibroblasts in osteoarthritis. International Immunopharmacology. 131. 111888–111888. 6 indexed citations
6.
Sheng, Gaohong, Tianqi Wang, Yuan Gao, Hua Wu, & Jian Wu. (2023). m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer. Scientific Reports. 13(1). 19670–19670. 3 indexed citations
7.
Sheng, Gaohong, Yuan Gao, Hua Wu, Yang Liu, & Yong Yang. (2023). Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis. Journal of Orthopaedic Surgery and Research. 18(1). 131–131. 11 indexed citations
8.
Wang, Tianqi, Fan Yang, Gaohong Sheng, et al.. (2023). Magnetofection of miR-21 promoted by electromagnetic field and iron oxide nanoparticles via the p38 MAPK pathway contributes to osteogenesis and angiogenesis for intervertebral fusion. Journal of Nanobiotechnology. 21(1). 27–27. 29 indexed citations
9.
Sheng, Gaohong, Yuan Gao, Qing Ding, et al.. (2023). P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization. Journal of Translational Medicine. 21(1). 132–132. 11 indexed citations
10.
Ding, Qing, Ruizhuo Zhang, Gaohong Sheng, et al.. (2023). Dioscin alleviates the progression of osteoarthritis: an in vitro and in vivo study. Journal of Inflammation. 20(1). 14–14. 4 indexed citations
11.
Wan, Junlai, Tianqi Wang, Zhiyi He, et al.. (2022). Flavokawain A alleviates the progression of mouse osteoarthritis: An in vitro and in vivo study. Frontiers in Bioengineering and Biotechnology. 10. 1071776–1071776. 2 indexed citations
12.
Sheng, Gaohong, et al.. (2021). Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature. BMC Pulmonary Medicine. 21(1). 138–138. 29 indexed citations
13.
Ding, Qing, Wei Qi, Gaohong Sheng, et al.. (2021). The Preventive Effect of Decorin on Epidural Fibrosis and Epidural Adhesions After Laminectomy. Frontiers in Pharmacology. 12. 774316–774316. 19 indexed citations
14.
Yan, Jiyuan, Bowei Ni, Gaohong Sheng, et al.. (2021). Rhoifolin Ameliorates Osteoarthritis via Regulating Autophagy. Frontiers in Pharmacology. 12. 661072–661072. 18 indexed citations
15.
Yan, Jiyuan, Yingchi Zhang, Gaohong Sheng, et al.. (2021). Selonsertib Alleviates the Progression of Rat Osteoarthritis: An in vitro and in vivo Study. Frontiers in Pharmacology. 12. 687033–687033. 7 indexed citations
16.
Yan, Jiyuan, Chaoxu Liu, Chang Tu, et al.. (2021). Hydrogel-hydroxyapatite-monomeric collagen type-I scaffold with low-frequency electromagnetic field treatment enhances osteochondral repair in rabbits. Stem Cell Research & Therapy. 12(1). 572–572. 39 indexed citations
17.
Ma, Tian, Jiachen Wang, Wenbin Liu, et al.. (2021). Low-frequency electromagnetic fields combined with tissue engineering techniques accelerate intervertebral fusion. Stem Cell Research & Therapy. 12(1). 143–143. 14 indexed citations
18.
Sheng, Gaohong, Yuan Gao, Yang Yong, & Hua Wu. (2021). Osteosarcoma and Metastasis. Frontiers in Oncology. 11. 780264–780264. 114 indexed citations
19.
Sheng, Gaohong, Peng Chen, Yanqiu Wei, et al.. (2019). Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis. CHEST Journal. 157(5). 1175–1187. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026